Participants with schizophrenia retain the information necessary for informed consent during clinical trials

OBJECTIVE: Cognitive impairment is a characteristic of schizophrenia. This impairment may affect the retention of information required for ongoing knowledgeable participation in clinical trials. This study monitored retention of study-related knowledge--including assessment of therapeutic misconcept...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Psychiatry
Autors principals: Fischer, Bernard A., McMahon, Robert P., Meyer, Walter A., Slack, Daniel J., Appelbaum, Paul S., Carpenter, William T.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4482016/
https://ncbi.nlm.nih.gov/pubmed/23842013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.12m07997
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars